| ACKNOWLEDGEMENTS | 第5-7页 |
| 摘要 | 第7-9页 |
| ABSTRACT | 第9-11页 |
| CHAPTER 1 Introduction | 第12-19页 |
| 1. WTO and TPP | 第12-13页 |
| 2. TPP's TRIPS-Plus Provisions on Patent Protection of Pharmaceutical Products | 第13-16页 |
| 3. Framework of the Thesis | 第16-19页 |
| 3.1 Focus of Previous Works | 第16页 |
| 3.2 Methodology | 第16-17页 |
| 3.3 Framework | 第17-19页 |
| CHPATER 2 Literature Review | 第19-26页 |
| 1. Comments on the TRIPS-Plus Provisions and Negative Influences on PublicHealth | 第19-21页 |
| 2. Policy Suggestions | 第21-23页 |
| 3. New Approaches | 第23-26页 |
| CHAPTER 3 Key Perspectives on Patent, Intellectual Property and Public Health | 第26-39页 |
| 1. Pharmaceutical Patents | 第26-27页 |
| 2. Intellectual Property Rights and Human Rights | 第27-30页 |
| 3. Intellectual Property Rights and Health Rights | 第30-32页 |
| 4. Patent System and Drug Accessibility | 第32-37页 |
| 4.1 Pharmaceutical Patents and Pharmaceutical Industry | 第32-35页 |
| 4.2 Drug Price and Drug Accessibility | 第35-37页 |
| 5. Conclusion | 第37-39页 |
| CHAPTER 4 Analysis and Comparisons of Legal Texts | 第39-58页 |
| 1. The Standard of Granting Pharmaceutical Patents | 第39-42页 |
| 2. The Scope of Patentable Subject Matter | 第42-44页 |
| 3. Patent Term Adjustment for Unreasonable Delays | 第44-48页 |
| 4. Data Exclusivity | 第48-52页 |
| 5. Pharmaceutical Patent Linkage | 第52-55页 |
| 6. Public Health Safeguards | 第55-56页 |
| 7. Conclusion | 第56-58页 |
| CHPATER 5 Cases Study | 第58-77页 |
| 1. Legal Cases Related to the TRIPS Agreement and Pharmaceutical Products | 第59-66页 |
| 1.1 United States vs. Brazil | 第59-61页 |
| 1.2 Big Pharma vs. Nelson Mandela | 第61-63页 |
| 1.3 The Novartis case | 第63-65页 |
| 1.4 Legal Cases Conclusion | 第65-66页 |
| 2. National Cases Related to Pharmaceutical Products and Public Health | 第66-77页 |
| 2.1 Developing Countries | 第66-72页 |
| 2.2 Developed Countries | 第72-75页 |
| 2.3 National Cases Conclusion | 第75-77页 |
| CHAPTER 6 Approaches towards the Conflicts between Public Health and PatentProtection | 第77-88页 |
| 1. Present Efforts | 第77-81页 |
| 1.1 Legal Approaches | 第77-79页 |
| 1.2 Other Approaches | 第79-81页 |
| 2. New Perspectives | 第81-88页 |
| 2.1 Asian Philosophy Perspective | 第82-83页 |
| 2.2 Ethical Approaches | 第83-86页 |
| 2.3 Global Cooperation between International Bodies | 第86-88页 |
| CHAPTER 7 Suggestions and Future Expectations | 第88-94页 |
| 1. Suggestions for Eliminating the Adverse Impacts of the TRIPS-Plus Provisionson Public Health | 第89-92页 |
| 1.1 Coordination of Specific Intellectual Property Provisions | 第89-90页 |
| 1.2 Coordination of Special Systems of Intellectual Property Rights | 第90-91页 |
| 1.3 Legislation of Specific Regulations on Public Health | 第91页 |
| 1.4 Efforts on the Integration of FTAs | 第91-92页 |
| 2. Future Expectations for the TPP | 第92-94页 |
| BIBILOGRAPHY | 第94-104页 |
